Expression of S6K1 in human visceral adipose tissue is upregulated in obesity and related to insulin resistance and inflammation

Acta Diabetologica

Volumn 52, Issue 2, 2014, Pages 257-266

  Catalán, Victoria ^a,b   Gómez Ambrosi, Javier ^a,b   Rodríguez, Amaia ^a,b   Ramírez, Beatriz ^a,b   Andrada, Patricia ^a   Rotellar, Fernando ^a,b   Valentí, Víctor ^a,b   Moncada, Rafael ^a   Martí, Pablo ^a   Silva, Camilo ^a,b   Salvador, Javier ^a,b   Frühbeck, Gema ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Adipose tissue; Inflammation; Insulin resistance; Obesity; S6K1

Indexed keywords

INSULIN; RIBOSOMAL PROTEIN S6 KINASE, 70KD, POLYPEPTIDE 1; S6 KINASE;

ENZYMOLOGY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; INSULIN RESISTANCE; INTRAABDOMINAL FAT; METABOLISM; MIDDLE AGED; OBESITY; UPREGULATION;

FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MIDDLE AGED; OBESITY; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; UP-REGULATION;

EID: 84939892924     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0632-9     Document Type: Article

References (48)

1. Frühbeck G, Toplak H, Woodward E, Yumuk V, Maislos M, Oppert JM (2013) Obesity: the gateway to ill health—an EASO position statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts 6:117–120
2. Ogden CL, Carroll MD, Kit BK, Flegal KM (2014) Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311:806–814
3. Frühbeck G, Gómez-Ambrosi J (2003) Control of body weight: a physiologic and transgenic perspective. Diabetologia 46:143–172
4. Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ, Burrell MA (2001) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 280:E827–E847
5. Poulain-Godefroy O, Lecoeur C, Pattou F, Frühbeck G, Froguel P (2008) Inflammation is associated with a decrease of lipogenic factors in omental fat in women. Am J Physiol Regul Integr Comp Physiol 295:R1–R7
6. Frühbeck G (2008) Overview of adipose tissue and its role in obesity and metabolic disorders. Methods Mol Biol 456:1–22
7. Apovian CM, Gokce N (2012) Obesity and cardiovascular disease. Circulation 125:1178–1182
8. Catalán V, Gómez-Ambrosi J, Rodríguez A, Frühbeck G (2013) Adipose tissue immunity and cancer. Frontiers 4:275
9. Johnson AM, Olefsky JM (2013) The origins and drivers of insulin resistance. Cell 152:673–684
10. Lumeng CN, Saltiel AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121:2111–2117
11. Nicholson JK, Holmes E, Kinross J et al (2012) Host-gut microbiota metabolic interactions. Science 336:1262–1267
12. Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148:852–871
13. Patti ME, Kahn BB (2004) Nutrient sensor links obesity with diabetes risk. Nat Med 10:1049–1050
14. Um SH, Frigerio F, Watanabe M et al (2004) Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431:200–205
15. Um SH, D’Alessio D, Thomas G (2006) Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3:393–402
16. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18:1926–1945
17. Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274–293
18. Howell JJ, Ricoult SJ, Ben-Sahra I, Manning BD (2013) A growing role for mTOR in promoting anabolic metabolism. Biochem Soc Trans 41:906–912
19. Tremblay F, Brule S, Hee Um S et al (2007) Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci USA 104:14056–14061
20. Pende M, Kozma SC, Jaquet M et al (2000) Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice. Nature 408:994–997
21. Yeh WC, Bierer BE, McKnight SL (1995) Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc Natl Acad Sci USA 92:11086–11090
22. Yang Z, Ming XF (2012) mTOR signalling: the molecular interface connecting metabolic stress, aging and cardiovascular diseases. Obes Rev 2:58–68
23. Lim HK, Choi YA, Park W et al (2003) Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway. J Biol Chem 278:45117–45127
24. Zhang J, Gao Z, Ye J (2013) Phosphorylation and degradation of S6K1 (p70S6K1) in response to persistent JNK1 Activation. Biochim Biophys Acta 2013:1980–1988
25. Di R, Wu X, Chang Z et al (2012) S6K inhibition renders cardiac protection against myocardial infarction through PDK1 phosphorylation of Akt. Biochem J 441:199–207
26. Gómez-Ambrosi J, Silva C, Galofré JC et al (2012) Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes 36:286–294
27. Gómez-Ambrosi J, Silva C, Catalán V et al (2012) Clinical usefulness of a new equation for estimating body fat. Diabetes Care 35:383–388
28. Gómez-Ambrosi J, Salvador J, Rotellar F et al (2006) Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obes Surg 16:262–269
29. Muruzábal FJ, Frühbeck G, Gómez-Ambrosi J, Archanco M, Burrell MA (2002) Immunocytochemical detection of leptin in non-mammalian vertebrate stomach. Gen Comp Endocrinol 128:149–152
30. Catalán V, Gómez-Ambrosi J, Rodríguez A et al (2013) Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: tumor necrosis factor-α stimulates mRNA levels of chemerin in visceral adipocytes from obese patients. Surg Obes Relat Dis 9:306–314
31. Catalán V, Gómez-Ambrosi J, Rotellar F et al (2007) Validation of endogenous control genes in human adipose tissue: relevance to obesity and obesity-associated type 2 diabetes mellitus. Horm Metab Res 39:495–500
32. Catalán V, Gómez-Ambrosi J, Ramírez B et al (2007) Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg 17:1464–1474
33. Krebs M, Roden M (2004) Nutrient-induced insulin resistance in human skeletal muscle. Curr Med Chem 11:901–908
34. Dann SG, Selvaraj A, Thomas G (2007) mTOR Complex1–S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 13:252–259
35. Khamzina L, Veilleux A, Bergeron S, Marette A (2005) Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146:1473–1481
36. Moreno-Navarrete JM, Ortega F, Sanchez-Garrido MA et al (2013) Phosphorylated S6K1 (Thr389) is a molecular adipose tissue marker of altered glucose tolerance. J Nutr Biochem 24:32–38
37. Krebs M, Brunmair B, Brehm A et al (2007) The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes 56:1600–1607
38. Tremblay F, Marette A (2001) Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. J Biol Chem 276:38052–38060
39. Adochio R, Leitner JW, Hedlund R, Draznin B (2009) Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85α subunit of phosphatidylinositol 3-kinase and S6K1 kinase. Endocrinology 150:1165–1173
40. Zheng Y, Zhang W, Pendleton E et al (2009) Improved insulin sensitivity by calorie restriction is associated with reduction of ERK and p70S6 K activities in the liver of obese Zucker rats. J Endocrinol 203:337–347
41. Treins C, Alliouachene S, Hassouna R, Xie Y, Birnbaum MJ, Pende M (2012) The combined deletion of S6K1 and Akt2 deteriorates glycemic control in a high-fat diet. Mol Cell Biol 32:4001–4011
42. Lee DF, Kuo HP, Chen CT et al (2007) IKKβ suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130:440–455
43. Zhang J, Gao Z, Yin J, Quon MJ, Ye J (2008) S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-α signaling through IKK2. J Biol Chem 283:35375–35382
44. Humar R, Kiefer FN, Berns H, Resink TJ, Battegay EJ (2002) Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J 16:771–780
45. Wouters BG, Koritzinsky M (2008) Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 8:851–864
46. Yu Y, Sato JD (1999) MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor. J Cell Physiol 178:235–246
47. Sabio G, Davis RJ (2010) cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance. Trends Biochem Sci 35:490–496
48. Han MS, Jung DY, Morel C et al (2013) JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 339:218–222